9-(4-(tert-Butyl)pyridin-2-yl)-9H-carbazol-2-ol, 97%, 5g

N-Bromophthalimide>95.0%(T)25g

4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one, 95.0%, 1g

4-(1H-pyrazol-1-yl)-2-butanone, 95.0%, 1g

4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 98%, 250mg

Bottiglia HPLC a collo multiplo DURAN® GL 45 quadrata con quattro colli laterali GL 45, 1 pezzo

(S)-3-Amino-3-(furan-2-yl)propanoic acid, 95.0%, 250mg

3-Bromo-2-nitropyridine, 98.0%, 10g

2-Chloro-6-methylbenzothiazole, 97.0%, 10g

4-AMINO-3,4-DIHYDRO-2H-PYRANO[3,2-B]PYRIDINE, 95.0%, 250mg

2-[2-Oxo-2-[4-(trifluoromethyl)phenyl]ethyl]propanedinitrile, 95+%, 1g

(S)-2-(((Benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoic acid, 95.0%, 5g

(2,3-Dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)methanol, 95+%, 250mg